Molecular profiling of DLBCL patients treated in the PETAL trial

Study ID Alternative Stable ID Type
EGAS00001005828 Other

Study Description

Using whole-exome sequencing and shallow whole genome sequencing for simultaneous screening of mutations, copy number alterations, and translocations, 5 biology-based risk profiles could be reproduced in an independent cohort of DLBCL patients, from the PETAL trial.

Study Datasets 1 dataset.

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID Description Technology Samples
Shallow whole genome sequencing and targeted sequencing of DLBCL patients treated in the PETAL trial
Illumina HiSeq 4000,Illumina NovaSeq 6000 216

Who archives the data?

There are no publications available